Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine

摘要

Methods of treating, preventing and/or managing myelodysplastic syndromes are disclosed. Specific methods encompass the administrations of 3-(4-amino-1-oxo-1,3- dihydro-isoindol-2-yl)-piperidin-2,6-dione in combination with 5-azacytidine.